New eczema drug shows promise in early trial
Disease control
Completed
This study tested an experimental drug called EVO301 in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug is safe and can reduce the severity and extent of eczema compared to a placebo. Participants received either EVO301 or a dummy tre…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC